PSYCH Symposium: Reassessing the Psychedelic Space

In the psychedelic sector a period of unabashed exuberance has given way to a sobering couple of years, with company valuations and investment tumbling amidst broader economic turmoil. Despite this challenging financial backdrop, a first-in-class psychedelic-assisted therapy could be approved as early as next year and public interest in these substances shows no sign of slowing. In this fireside discussion with Christian Angermayer we revisit some of the key tenets of the investor’s thesis and explore what the future might look like for the psychedelic space. Featuring: Christian Angermayer, Christian Angermayer, Founder, Apeiron Investment Group. Josh Hardman, Founder & Editor, Psychedelic Alpha.